203 related articles for article (PubMed ID: 35703080)
1. Care pathways for people with major depressive disorder: a European Brain Council Value of Treatment study.
Strawbridge R; McCrone P; Ulrichsen A; Zahn R; Eberhard J; Wasserman D; Brambilla P; Schiena G; Hegerl U; Balazs J; Caldas de Almeida J; Antunes A; Baltzis S; Carli V; Quoidbach V; Boyer P; Young AH
Eur Psychiatry; 2022 Jun; 65(1):1-21. PubMed ID: 35703080
[TBL] [Abstract][Full Text] [Related]
2. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study.
Arias-de la Torre J; Vilagut G; Ronaldson A; Serrano-Blanco A; Martín V; Peters M; Valderas JM; Dregan A; Alonso J
Lancet Public Health; 2021 Oct; 6(10):e729-e738. PubMed ID: 33961802
[TBL] [Abstract][Full Text] [Related]
4. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
5. A Web-based screening instrument for depression and anxiety disorders in primary care.
Farvolden P; McBride C; Bagby RM; Ravitz P
J Med Internet Res; 2003; 5(3):e23. PubMed ID: 14517114
[TBL] [Abstract][Full Text] [Related]
6. The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder.
Schwartz OS; Amminger P; Baune BT; Bedi G; Berk M; Cotton SM; Daglas-Georgiou R; Glozier N; Harrison B; Hermens DF; Jennings E; Lagopoulos J; Loo C; Mallawaarachchi S; Martin D; Phelan B; Read N; Rodgers A; Schmaal L; Somogyi AA; Thurston L; Weller A; Davey CG
Trials; 2023 Oct; 24(1):686. PubMed ID: 37875938
[TBL] [Abstract][Full Text] [Related]
7. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.
Setiawan E; Attwells S; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Xu C; Sharma S; Kish S; Houle S; Meyer JH
Lancet Psychiatry; 2018 Apr; 5(4):339-347. PubMed ID: 29496589
[TBL] [Abstract][Full Text] [Related]
8. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.
Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA
Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709
[TBL] [Abstract][Full Text] [Related]
9. A screening algorithm for early detection of major depressive disorder in head and neck cancer patients post-treatment: Longitudinal study.
Henry M; Rosberger Z; Ianovski LE; Hier M; Zeitouni A; Kost K; Mlynarek A; Black M; MacDonald C; Richardson K; Zhang X; Fuhrmann F; Chartier G; Frenkiel S
Psychooncology; 2018 Jun; 27(6):1622-1628. PubMed ID: 29532541
[TBL] [Abstract][Full Text] [Related]
10. Serum Brain-Derived Neurotrophic Factors in Taiwanese Patients with Drug-Naïve First-Episode Major Depressive Disorder: Effects of Antidepressants.
Chiou YJ; Huang TL
Int J Neuropsychopharmacol; 2017 Mar; 20(3):213-218. PubMed ID: 27811136
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal population-based study exploring treatment utilization and suicidal ideation and behavior in major depressive disorder.
Chartrand H; Robinson J; Bolton JM
J Affect Disord; 2012 Dec; 141(2-3):237-45. PubMed ID: 22703701
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries.
Lloyd CE; Nouwen A; Sartorius N; Ahmed HU; Alvarez A; Bahendeka S; Basangwa D; Bobrov AE; Boden S; Bulgari V; Burti L; Chaturvedi SK; Cimino LC; Gaebel W; de Girolamo G; Gondek TM; de Braude MG; Guntupalli A; Heinze MG; Ji L; Hong X; Khan A; Kiejna A; Kokoszka A; Kamala T; Lalic NM; Lecic Tosevski D; Mankovsky B; Li M; Musau A; Müssig K; Ndetei D; Rabbani G; Srikanta SS; Starostina EG; Shevchuk M; Taj R; Vukovic O; Wölwer W; Xin Y
Diabet Med; 2018 Jun; 35(6):760-769. PubMed ID: 29478265
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
15. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study.
Lee W; Sheehan C; Chye R; Chang S; Bayes A; Loo C; Draper B; Agar MR; Currow DC
PLoS One; 2023; 18(11):e0290876. PubMed ID: 37963146
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers.
Pasman JA; Meijsen JJ; Haram M; Kowalec K; Harder A; Xiong Y; Nguyen TD; Jangmo A; Shorter JR; Bergstedt J; Das U; Zetterberg R; Tate A; Lichtenstein P; Larsson H; Odsbu I; Werge T; Reichborn-Kjennerud T; Andreassen OA; Sullivan PF; Buil A; Tesli M; Lu Y
Lancet Reg Health Eur; 2023 Jun; 29():100621. PubMed ID: 37265784
[TBL] [Abstract][Full Text] [Related]
18. Detection of major depressive disorder in primary care patients.
Froom J; Schlager DS; Steneker S; Jaffe A
J Am Board Fam Pract; 1993; 6(1):5-11. PubMed ID: 8421930
[TBL] [Abstract][Full Text] [Related]
19. Community mental health interventions for people with major depressive disorder: A scoping review.
Tan RXR; Goh YS
Int J Ment Health Nurs; 2022 Dec; 31(6):1315-1359. PubMed ID: 35695678
[TBL] [Abstract][Full Text] [Related]
20. Time heals all wounds? A 2-year longitudinal diffusion tensor imaging study in major depressive disorder.
Repple J; Zaremba D; Meinert S; Grotegerd D; Redlich R; Förster K; Dohm K; Opel N; Hahn T; Enneking V; Leehr EJ; Böhnlein J; Dzvonyar F; Sindermann L; Winter N; Goltermann J; Kugel H; Bauer J; Heindel W; Arolt V; Dannlowski U
J Psychiatry Neurosci; 2019 Nov; 44(6):407-413. PubMed ID: 31094489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
